Darin Falk holds a Doctor of Philosophy degree in Cell/Cellular and Molecular Biology from the University of Florida. Currently, Darin is the CEO of NeuBio Consulting, LLC and also serves as the Chief Scientific Officer at Lacerta Therapeutics. Prior to these roles, Darin held positions at the University of Florida including Assistant Professor.
Current role